Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer.
- Resource Type
- Academic Journal
- Source
Cancer Chemotherapy & Pharmacology (CANCER CHEMOTHER PHARMACOL), Mar2024; 93(3): 191-202. (12p)- Subject
- Language
- English
- ISSN
- 0344-5704